Breaking News

Chiltern Boosts Investment in Endpoint Clinical

Chiltern International Ltd. will make an additional financial investment in Endpoint Clinical, Inc., as part of an effort to further strengthen their strategic partnership, which was established in April 2009.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Chiltern International Ltd. will make an additional financial investment in Endpoint Clinical, Inc., as part of an effort to further strengthen their strategic partnership, which was established in April 2009. Glenn Kerkhof, Chiltern’s chief executive officer, said, “Chiltern’s decision to increase our investment in endpoint reflects our aligned vision for the future of endpoint’s PULSE platform, enabling endpoint to provide an unparalleled combination of premium client service and advanced tec...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters